N. Azad

Multiclonal colorectal cancers with divergent histomorphological features and RAS mutations: one cancer or separate cancers?

E. Montgomery, J. Eshleman, Ming-Tseh Lin, 2020, Human pathology.

Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer

M. Makary, J. Cameron, E. Fishman, 2017, Cancer medicine.

RAD51B Harbors Germline Mutations Associated With Pancreatic Ductal Adenocarcinoma.

Vikesh K. Singh, A. Zaheer, Kui Wu, 2022, JCO precision oncology.

Surgery for colorectal liver metastases: The evolution of determining prognosis.

A. Ejaz, G. Spolverato, T. Pawlik, 2013, World journal of gastrointestinal oncology.

Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal Cancer

Ming-Tseh Lin, E. Jaffee, D. Brennan, 2022, Current oncology.

Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017

Vikesh K. Singh, J. Cameron, A. Zaheer, 2020, Cancer letters.

Gastrointestinal ostomies and sexual outcomes: a comparison of colorectal cancer patients by ostomy status

J. Efron, J. Haythornthwaite, P. Finan, 2013, Supportive Care in Cancer.

A first-in-human phase I study of MORAb-004 (MOR4), a humanized monoclonal antibody recognizing TEM-1 (endosialin), in patients with solid tumors.

M. Gounder, L. Old, R. Carvajal, 2011, Journal of Clinical Oncology.